Fenmetramide CAS 5588-29-4
| CAS No. | 5588-29-4 |
| Molecular Formula | C11H13NO2 |
| Molecular Weight | 191.23 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Fenmetramide (CAS 5588-29-4), molecular formula C11H13NO2 and molecular weight 191.23 g/mol, is a CATO reference standard with documented purity and traceability.
The molecular framework of Fenmetramide (C11H13NO2) is characterized by an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
CATO manufactures Fenmetramide under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C11H13NO2 |
| Molecular Weight | 191.23 g/mol |
| Appearance | Off-white to pale yellow crystalline powder |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1958 |
| Nitrogen Atoms | 1 |
Recommended Standards
- N-Nitroso Levodropropizine EP Impurity B (CAS 14340-33-1)
- (R,S)-N-Nitroso Anabasine (CAS 37620-20-5)
- Carteolol Impurity 33 (CAS 34685-03-5)
- N-Nitrosoanabasine (CAS 1133-64-8)
- (S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentan-1-amine (CAS 1259365-03-1)
- 2-(4-Chloro-2-fluorophenyl)propan-2-ol (CAS 1537457-36-5)
- ent-Protolichesterinic Acid (CAS 1448-96-0)
- Levocabastine Hydrochloride EP Impurity I (CAS CATO-C4X-228925)
- 8-(2,2,2-Trifluoroacetyl)-2,3-dihydroimidazo[1,2-a]pyridin-5(1H)-one (CAS 1263212-95-8)
- tert-butyl 4-(methylsulfonyloxymethyl)-2-azabicyclo[2.1.1]hexane-2-carboxylate (CAS 220598-36-7)
- Moxifloxacin impurity 168 (CAS CATO-C4X-1074168)
- 5-(2-Methylthiazol-4-yl)-1,2,4-oxadiazole-3-carboxylic acid (CAS 1519288-12-0)
- 2-({[(4-methylphenyl)carbamoyl]methyl}sulfanyl)benzoic acid (CAS 398997-40-5)
- C-telopeptide (CAS 162929-64-8)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com